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hardware and software to overcome artefacts associated with extreme
beam hardening in metals.
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CALCIUM-DEPENDENT ACTOMYOSIN CONTRACTILITY IN OSTEOCYTES
UNDER MECHANICAL LOADING
Edward Guo
Columbia University, USA
Intracellular Ca+2 ([Ca+2]i) oscillations, mediated by mechanosensitive Ca
+2
channels and the ER Ca+2 store, have been observed in osteocytes in
response to mechanical loading in vitro and ex vivo in our laboratory. While
many distant downstream gene expression pathways of [Ca+2]i signaling have
been studied, the immediate, temporally-regulated effects of these
numerous [Ca+2]i oscillations in osteocytes have not been elucidated. A
recent study in the gene expression of primary osteocytes has suggested
high levels of muscle contraction-related proteins. A hallmark of muscle is
its [Ca+2]i-dependent actomyosin contractility. We hypothesized thatosteocytes utilize [Ca+2]i oscillations to activate pulsing, muscle-like con-
tractile mechanical behavior. In this study, we used a quasi-3D imaging tech-
nique to simultaneously measure the contractile behavior of the actin
networks and [Ca+2]i in single osteocytes.
[Ca+2]i spikes were induced using fluid flow, ATP, or ionomycin in MLO-Y4 os-
teocytes. Contraction in the actin networks was measured immediately upon
onset of [Ca+2]i influx in all groups, indicated by a decrease in the strain
value. Microtubule networks did not display a similar contractile response.
Longer imaging of actin contractions displayed reversible, phasic contrac-
tions in the actin networks over a period of w180 s.
As non-muscle and smooth muscle myosin II isoforms are regulated by myosin
light chain kinase (MLCK) and skeletal and cardiac myosin II isoforms by
troponins, we sought to determine the myosin responsible for the observed
contraction. Under ATP stimulation, MLCK inhibition by ML-7 drastically
altered the kinetics of contraction, but skeletal and non-muscle myosin II
inhibition by blebbistatin had no effect. This pointed towards a smooth
muscle myosin mediated contraction. Furthermore, we verified the presence
of smooth muscle myosin heavy chain (SMMHC) in primary osteocytes and
MLO-Y4 osteocytes.
Here, we demonstrate a novel osteocyte mechano- and transduction
behavior where [Ca+2]i oscillations activate dynamic actomyosin contrac-
tions. Future studies will verify this mechanism in ex vivo osteocytes, as
well as investigate downstream behaviors of contractility in osteocytes,
such as contractility-mediated vesicle exocytosis.
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TRACING STEM CELLS USING IN VIVO IMAGING TECHNIQUES IN BONE
REPAIR AND CANCER RESEARCH
Gang Li
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Regenerative medicine with the use of stem cells is the therapeutic
alternative for many disease states. Questions remain regarding the viability
200 Abstractsand biology of transplanted stem cells in the living subject. Recent advances
in molecular biology and imaging have allowed the successful non-invasive
monitoring of transplanted stem cells in the living subject. The ideal imaging
method should provide the information of (1) Real-time visualization of stem
cell delivery; and (2) Determination of location(s) and Quantification of cells
over time. The chosen labeling modality should not interact with the normal
functions of the stem cell and provides a good contrast between background
and the target signal under study, achieving a large signal-to-noise ratio.
Reporter gene-bioluminescence imaging (BLI) is based on light emission and
detection by specific cooled charge coupled device (CCD) cameras. Similar
to other reporter gene strategies, the BLI signal is only emitted when cells
are viable, and thus can be used for the longitudinal monitoring of stem cell
survival and study of cell status. BLI has been successfully used for in vivo
study of cell delivery and monitoring of stem cell viability, fate, interaction
between stem cells and microenvironments in small living animals.
We have investigated the distribution of systemically delivered luciferase
labeled MSCs in fracture animal model and tumor bearing animals. The
whereabouts of the labelled stem cells are monitored using the in vivo im-
aging system (IVIS 200, Exogen, USA), and accessed the efficiency of using
stem cells therapy for promoting fracture repair (Fig. 1) and anti-cancer
gene therapy.
Fig. 1. Allogenic Luc-MSCs were injected into the fracture site in mice, and
were monitored using in vivo imaging system. Allogenic MSCs became
undectable 14 days after injection. All animals did not show obvious adverse
side effects.
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Optical imaging techniques are among the most powerful techniques in
preclinical research, specifically for the imaging of rodents. It includes (i)
methods suited for mesoscopic (spatial resolution of about 1 mm) whole
body non-invasive imaging, specifically fluorescent and bioluminescent
imaging, (ii) microscopic techniques, most notably multiphoton and confocal
microscopy, and (iii) spectroscopic approaches such as Raman and Fourier
Transform Infrared imaging and mass spectroscopy imaging.A key reason for the attractiveness of optical imaging is the possibility to
exploit the extremely powerful methods of genetic engineering. For
example, transgenic mouse models can be generated that feature near
infrared reporter signals associated with specific gene expression. By this
mechanism of molecular imaging, morphologic imaging can be extended to
in vivo functional imaging.
Optical imaging of bone is feasible but presents specific hurdles that to date
have only partially been overcome. Light is strongly scattered and absorbed
leading to strong attenuation and resulting limits in spatial resolution,
decreasing rapidly with increasing depth. This also leads to bias in the
quantitative evaluation of optical signals. On the positive side, due to the
strong bone binding properties of bisphosphonates, bone labeling molecules
have been developed. These bind to mineral on bone surface and permit in
vivo insight into bone turnover. In this way, they work similar to serum
markers of bone turnover, but they provide this information in a spatially
resolved way, including 3-D depiction using fluorescent molecular tomogra-
phy (FMT).
Ex vivo optical imaging provides powerful assessment tools specifically for
the organic components of bone tissue. Second harmonic generation (SHG) is
a contrast mechanism of multiphoton microscopy specific to collagen.
Mineral to matrix ratios and subtype analysis of collagen is feasible with
the aforementioned spectroscopic imaging approaches, promising to help
elucidating bone fragility in secondary osteoporosis and other disorders, e.g.
effects of diabetes on bone.
The goals for research in the coming years include the refinement of these
methods, the linking of mesoscopic with microscopy techniques in order to
obtain a comprehensive assessment of as many dimensions of bone quality as
possible, the in vivo assessment of bone function down to the cellular level,
in order to improve the assessment of bone metabolism and other skeletal
disorders.
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Dr. Claus-C. Glu¨er is a Professor of Medical Physics at the Department of
Radiology and Neuroradiology, University Hospital Schleswig-Holstein in Kiel,
Christian-Albrechts-Universita¨t zu Kiel, Germany. His research is aimed at
the development of innovative parametric imaging techniques and their
quantitative evaluation. Since 1987 when he started his postdoc in the Oste-
oporosis Research Group of Prof. Harry K. Genant at the University of Cali-
fornia, San Francisco, Dr Glu¨er has focused his research on osteoporosis
and other bone disorders. He has contributed specifically to the develop-
ment of bone densitometry, quantitative ultrasound and high resolution
computed tomography approaches. He has coordinated several multicentre
studies including OPUS, a European project on epidemiology and optimised
diagnostic assessment of osteoporosis.
Dr. Glu¨er also has a strong research interest in multimodal methods for
molecular imaging with applications in oncology, inflammation, and skeletal
research. He co-founded the Molecular Imaging North Competence Center
(MOIN CC) at the Christian-Albrechts-Universita¨t zu Kiel, a preclinical imag-
ing lab. At MOIN CC, multi modal imaging studies combining micro computed
tomography, high-field magnetic resonance imaging, high resolution ultra-
sound, fluorescence and bioluminescence imaging can be carried out to
study morphological, functional, cellular, and molecular processes in health
and disease and to assess therapeutic effects.
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